MED.00130 Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring

- Policy addresses surface electromyography (sEMG) and electrodermal activity sensor devices for seizure monitoring (e.g., SPEAC System). - Coverage determination: Investigational/experimental and not medically necessary; therefore, not covered. - Limitations: No covered indications or settings, including adjunct use in the home or healthcare facilities during rest; related claims (e.g., HCPCS/CPT E0746, E1399, S3900; epilepsy ICD-10 codes such as G40.001, G40.919) are not covered.

"The use of surface electromyography (sEMG) or electrodermal activity sensor devices for seizure monitoring is consideredinvestigational and not medically necessary."

Sign up to see full coverage criteria, indications, and limitations.